OKLAHOMA · CONTRACT FOR CARE EVIDENCE
Advanced Pain Management Center of Oklahoma — 2020 Opioid Agreement
A historical public new-patient packet preserved from the practice website contains an “Informed Consent for Opioid Treatment.” The current 2026 practice website now routes new-patient paperwork through its patient portal, so Seeds of Vice does not represent this 2020 form as the current operative agreement unless the practice confirms it.
Document provenance
- Institution: Advanced Pain Management Center of Oklahoma, LLC.
- Document: New Patient Packet containing “Informed Consent for Opioid Treatment.”
- Public source: practice-hosted PDF.
- Historical version indicator: public file name / packet identifies a 2020-era version.
- Current-use status: unresolved. The current practice website says new-patient paperwork is completed through a secure portal rather than exposing the operative forms publicly.
- Practice verification: not yet received.
Material terms preserved in the historical form
The agreement states that opioid therapy is conditioned on a series of patient obligations. Seeds of Vice records the requirements separately from the question of whether Oklahoma law requires the same implementation.
- One-prescriber restriction: the patient agrees not to request or accept controlled-substance medication from another physician or individual while receiving such medication from the pain center.
- Termination consequences: the document states that drug hoarding, acquiring opioid medication or adjunctive analgesia from other physicians, uncontrolled dose changes, lost prescriptions, or failure to follow the agreement may result in termination of the doctor-patient relationship.
- Same-pharmacy / refill controls: the form states a maximum one-month refill supply, use of the same pharmacy, office-visit / regular-office-hours refill requirements, and no emergency or walk-in opioid refills.
- Medication container requirement: the form requires patients to bring opioid and adjunctive medications in original containers at every visit.
- Monthly visits: the form states the patient will be seen monthly and receive medication intended to last from appointment to appointment.
- Random urine testing: the patient agrees to random or unannounced urine testing; refusal or specified results can lead to treatment-plan changes, opioid discontinuation, or termination.
- Substance restrictions: the document addresses illicit substances, including marijuana in the historical wording, with potential changes in treatment or termination.
- Function-based continuation: the form says opioids may be discontinued when the physician determines there is no improvement in daily function or quality of life.
- Family / third-party communication: the form authorizes contact with health professionals, family, pharmacy, legal authority, or regulatory agencies when the physician considers it necessary and includes a possible family/friend conference.
Authority classification
Oklahoma law contemplates several of these subjects without necessarily requiring this exact clinic implementation. Patient-provider agreements may address other prescribers, refill conditions, monitoring measures such as specimen screening and pill counts, treatment modalities, and termination consequences. Clinic-specific frequency, pharmacy, appointment, testing, and discharge rules require separate classification rather than being presented as statewide mandates.
Seeds of Vice is preserving this document as historical institutional evidence. Any statement about the current policy, enforceability of a clause, or legality of a particular implementation remains subject to current-source verification and, where needed, legal review.
Practice verification requested
Advanced Pain Management Center of Oklahoma can provide the current agreement, revision date, corrections, or context through the Oklahoma practice-verification portal. A supported correction will be incorporated while the historical version remains preserved as a dated record.